CorMedix Announces Enrollment and Dosing of First Patient in Phase 3 Neutrolin® Trial in Hemodialysis

Written by Janine McCargo on December 14, 2015

Bedminster, NJ – December 14, 2015 – CorMedix Inc. (NYSE…